The St Louis-based pharmacy benefit management company reported third quarter net income of $661.7 million, or $1.45 per share on revenue of $25.22 billion.
Analysts on average were expecting the company to report earnings of $1.44 per share on revenue of $26.33 billion.
For the current quarter, the company provided earnings guidance between $1.54 and $1.58 per share versus analysts' consensus $1.53 per share expectations.
Separately, TheStreet Ratings team rates EXPRESS SCRIPTS HOLDING CO as a Buy with a ratings score of A-. TheStreet Ratings Team has this to say about their recommendation:
We rate EXPRESS SCRIPTS HOLDING CO (ESRX) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, notable return on equity and good cash flow from operations. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.